DONALD MACPHAIL: Open Payments
NPI 1851915334 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,671 in 101 payments from 21 companies in 2025. Trend: 2023 $1,192 · 2024 $1,178 · 2025 $1,671
Food & beverage: $1,671
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $278 |
| ABBVIE INC. | 16 | $252 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $237 |
| PFIZER INC. | 13 | $192 |
| Axsome Therapeutics, Inc. | 10 | $159 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Amgen Inc. | 5 | $87 |
| Biogen, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $49 |
| Antares Pharma, Inc. | 3 | $47 |
Products named: CAPLYTA, Wegovy, Auvelity, NURTEC ODT, VRAYLAR, REXULTI, Ozempic, QULIPTA.
Industry payments across MI — which companies pay providers there.
